State Street Corp Pharvaris N.V. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Pharvaris N.V. stock. As of the latest transaction made, State Street Corp holds 92,006 shares of PHVS stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,006
Previous 53,980
70.44%
Holding current value
$1.16 Million
Previous $999,000
76.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$95 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$55.5 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$54.1 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$46.1 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$41.7 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $426M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...